Postmastectomy radiation therapy in women with T1–T2 tumors and 1 to 3 positive lymph nodes: analysis of the breast international group 02-98 trial—a letter to the editor

We would like to thank Gregucci et al. for their interest and analysis of our publication “Postmastectomy radiation therapy in women with T1–T2 tumors and 1 to 3 positive lymph nodes: analysis of the breast international group 02-98 trial” in which we highlighted the benefit of PMRT for patients with T1–T2 breast cancer and 1–3 positive LNs in the setting of modern chemotherapy.